NPF Centers Make the News!

Categories: News, NPF News, Other

Boston Neighborhood Network (BNN) recently interviewed NPF co-founder Jane Holt to discuss the newly designated NPF Centers as well as progress being made in the treatment of pancreatic diseases.

FDA approves new treatment for advanced pancreatic cancer

Categories: News, NPF News, Other

The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy. According to the National Cancer Institute, there will be 48,960 new cases of pancreatic cancer diagnosed in the U.S. in 2015, …

Read More